These data, together with our findings, indicate a neuroprotective role of NMNAT3 that might be diminished in PD due to decreased levels of NMNAT3 protein, as reported here both in patient’s brain and upon disease-related expression of α-syn in a cellular model of PD. This evidence concerns the gene NMNAT3 and Parkinson disease.